Article
US FDA approves Pfizer's next-generation pneumococcal vaccine
Rating:
0.0
Views:
55
Likes:
1
Library:
1
The U.S. Food and Drug Administration (FDA) has approved Pfizer Inc's next-generation vaccine to prevent pneumococcal disease in children aged six weeks to 17 years, the company said late on Thursday.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value